- Home
- / ShareHope Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ShareHope Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$30
2024-10-29
Market Capitalization
NT$3.9 B
2024-10-29
Revenue
NT$4.3 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.1B | 3.1B | 4.1B | 3.9B | 4.1B | 3.9B | 4.3B |
| Cost of goods sold | 2.4B | 2.3B | 2.7B | 2.7B | 2.8B | 2.8B | 3.3B |
| Gross profit | 656.7M | 866.9M | 1.4B | 1.2B | 1.4B | 1.1B | 1.1B |
| Gross profit margin, % | 27.8% | 34.5% | 30.0% | 32.9% | 27.7% | 24.3% | |
| Operating expense total | 444.1M | 546.4M | 706.9M | 664.4M | 734.4M | 709.5M | 739.3M |
| Depreciation and amortization | 138.0M | 202.4M | 216.4M | 304.5M | 305.8M | 320.6M | 307.6M |
| EBITDA | 212.6M | 315.9M | 707.1M | 491.8M | 628.0M | 361.3M | 314.2M |
| EBITDA margin, % | 10.1% | 17.3% | 12.8% | 15.2% | 9.3% | 7.3% | |
| EBIT | 104.1M | 157.6M | 489.4M | 250.4M | 367.5M | 153.7M | 223.5M |
| EBIT margin, % | 5.0% | 11.9% | 6.5% | 8.9% | 4.0% | 5.2% | |
| Interest income | 1.7M | 1.5M | 1.2M | 1.3M | 3.1M | 8.3M | 10.5M |
| Interest expense | 13.7M | 15.6M | 14.5M | 20.1M | 38.2M | 53.7M | 58.3M |
| Pre tax profit | 165.3M | 204.3M | 479.1M | 267.6M | 339.9M | 109.0M | 173.9M |
| Income tax expense | 31.7M | 25.1M | 118.0M | 74.2M | 95.8M | 53.7M | 51.5M |
| Net Income | 133.6M | 179.2M | 361.1M | 193.4M | 244.1M | 55.3M | 122.4M |